ACTRN12615001083583已完成1 期
A single dose, randomized, blinded, 4 way crossover pilot pharmacokinetic study of 3 test formulations of isotretinoin capsules against the innovator isotretinoin capsule conducted under fasting conditions in healthy male volunteers
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- Male
入选标准
- •Healthy males
- •Aged between 18 and 55 years
- •Non-smoker
- •BMI greater than or equal to 19 and less than 30 inclusive
- •Normal, healthy individuals as determined by medical history, physical examination, ECG, blood pressure and laboratory tests
- •Drug free as determined by urine drug testing
- •Able to comply with the study restrictions
- •Able to provide written information consent
排除标准
- •Concomitant drug therapy of any kind
- •History of depression or other mental illness, or a history of epilepsy or seizures
- •History of conditions that might interfere with the absorption, distribution, metabolism or excretion of the drug
- •History of alcohol or drug abuse or dependency
- •Sensitivities to Vitamin A or food such as liver
- •Participation in a drug study within 60 days of the start of the study or undertaking to donate blood within 60 days after the completion of the study
- •Sensitivities to isotretinoin, its excipients or any other retinoids
- •Individuals for whom the Clinical Investigator believes, for any reason, that participation would not be an acceptable risk
研究者
相似试验
已完成
1 期
Comparative assessment in healthy male volunteers under fasting conditions of the absorption and pharmacokinetics of a test formulation of isotretinoin capsule against an innovator isotretinoin capsule in a pilot studyAcneACTRN12616000663459Zenith Technology Corporation Limited16
已完成
不适用
A single dose, randomized, four-way cross-over, bioavailability and food interaction study of PedPRM (Pediatric Prolonged Release Melatonin, Neurim Pharmaceuticals Ltd) and Circadin® tablets in healthy male and female volunteers.InsomniaNL-OMON44644eurim Pharmaceuticals Ltd24
进行中（未招募）
不适用
Relative bioavailability of oral suspension of rivaroxaban compared to standard tablethealthy volunteers (Prevention and teatment of thromboembolic disorders)MedDRA version: 14.1Level: LLTClassification code 10043640Term: Thrombosis venousSystem Organ Class: 100000004866EUCTR2013-001720-19-DEBayer HealthCare AG
已完成
不适用
A single dose, 4-way crossover, double-blind, placebo-controlled, randomized study to investigate the effect of JNJ-42847922 on polysomnography (PSG) measures in subjects with major depressive disorder with insomnia who are stably treated with antidepressants.Depression10027946InsomniaNL-OMON40706Janssen-Cilag10
已完成
不适用
A Single-Dose, Open-Label, Randomized, 4-Way Crossover Pivotal Study to Assess the Bioequivalence of Canagliflozin when Administered as the Monohydrate form to the Hemihydrate form in Healthy Adult Subjects under Fasted Conditionsglucose-lowering therapyglycemic control10018424NL-OMON42409Janssen-Cilag44